SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

51,190.24 242.68
(0.48%)

Dow Jones

7,742.36 54.91
(0.71%)

Hang Seng

68,256.51 -700.21
(-1.02%)

Nikkei 225

10,455.36 27.09
(0.26%)

Forex

USD-INR

96.17 0.25
(0.26%)

EUR-INR

108.49 -0.30
(-0.28%)

GBP-INR

127.16 -0.03
(-0.02%)

JPY-INR

0.61 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

655.111941

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

33.57

47417.52

EPS(TTM)

Face Value()

Div & Yield %

85.6

0.7

Back

Jaykay Enterprises consolidated net profit declines 78.19% in the June 2026 quarter

Aug 15,2026

Net profit of Jaykay Enterprises declined 78.19% to Rs 4.41 crore in the quarter ended June 2026 as against Rs 20.22 crore during the previous quarter ended June 2025. Sales rose 34.48% to Rs 74.57 crore in the quarter ended June 2026 as against Rs 55.45 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	74.57	55.45	34
OPM %	14.24	12.43	-
PBDT	12.41	27.57	-55
PBT	7.29	23.65	-69
NP	4.41	20.22	-78

71,909.70 -570.59 ( -0.79%)

51,190.24 242.68 (0.48%)

7,742.36 54.91 (0.71%)

68,256.51 -700.21 (-1.02%)

10,455.36 27.09 (0.26%)

96.17 0.25 (0.26%)

108.49 -0.30 (-0.28%)

127.16 -0.03 (-0.02%)

0.61 0.00 (-0.36%)